Prevalence of Ejaculatory Disorders among Post COVID-19 Egyptian Males | ||||
| International Journal of Medical Arts | ||||
| Article 3, Volume 6, Issue 6, June 2024, Page 4493-4501 PDF (1.8 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ijma.2024.288948.1967 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Amr Abd El-Wahed Mohammed Nada  1; Abd El-Shakour Abd El-Hafeez Al-Mohammady2; Ahmed Mohammed Said Kadah2
| ||||
| 1Department of Dermatology, Venereology and Andrology, Seidi Ghazy Central Hospital, Ministry of Health, Kafrelsheikh, Egypt | ||||
| 2Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt | ||||
| Abstract | ||||
| Background: Sexual activity and reproductive health are becoming more widely acknowledged as crucial indicators of good health and a high standard of living. The coronavirus disease [COVID-19] pandemic impacted sexual activity both during and after the pandemic. Aim of the work: To determine whether ejaculatory disorders [EJD] were impacted in any way by the COVID-19 epidemic. Patients and Methods: This research was done retrospectively on 1000 male COVID-19 patients. Patients were requested to complete the Male Sexual Health Questionnaire Ejaculatory Dysfunction [MSHQ-EjD] Short Form, the Sexual Health Inventory for Men questionnaire [SHIM], and the International Index of Erectile Function [IIEF]. Results: Normal ejaculation was reported by 31.2% of participants. However, 32.5% reported premature ejaculation [PE], followed by delayed ejaculation [DE] [22%] and retrograde ejaculation [14.3%]. The total score of MSHQ-EjD was significantly higher among normal individuals [4.62 ± 0.48] than in PE [2.07 ± 0.868], DE [2.21 ± 0.77], and retrograde ejaculation [2.29 ± 0.803] [P<0.001]. According to the total score of SHIM, severe EJD was detected among 78.8, 70.5, and 78.3% of PE, DE and retrograde ejaculation patients, respectively. The IIEF score was 16.74 ± 2.44. Intercourse satisfaction mean score was 5.99 ± 2.06, and orgasmic function [OF] score was 3.28 ± 1.2. The Mean of the sexual desire [SD] and overall satisfaction were 5.36 ± 1.25 and 7.07 ± 1.098, respectively. The severity of COVID-19 associated significantly with EJD [P=0.008], strength degree [P<0.001], SHIM score [P<0.001], and SD score [P=0.023]. Patient hospitalization associated significantly with EJD [P<0.001], strength [P=0.005], volume [P=0.038], SHIM score [P=0.002], and OF score [P=0.001]. Conclusion: The severity of COVID-19 disease was associated significantly with sexual desire among EJD patients. Due to the importance of consistent treatment, social media should be used to maintain communication with physicians and continue appropriate medications. | ||||
| Keywords | ||||
| COVID-19; Ejaculatory Disorders; Prevalence; Sexual Life; Male | ||||
|
Statistics Article View: 173 PDF Download: 108 |
||||
